Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation

Stem Cells and Development

Volumn 18, Issue 9, 2009, Pages 1243-1245

  Ringdén, Olle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB;

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BREAST CANCER; CYTOMEGALOVIRUS INFECTION; DONOR LYMPHOCYTE INFUSION; EDITORIAL; EPSTEIN BARR VIRUS; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MEGAKARYOCYTE; MESENCHYMAL STROMAL CELL; MESENCHYME CELL; NEUTROPHIL COUNT; NONHUMAN; OSTEOCLAST; PILOT STUDY; PRIORITY JOURNAL; RETRANSPLANTATION; STROMA CELL; THROMBOCYTE COUNT;

GRAFT REJECTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MYELODYSPLASTIC SYNDROMES; RECOVERY OF FUNCTION; REMISSION INDUCTION; STROMAL CELLS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 70450214140     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.1809.edi     Document Type: Editorial

References (28)

1. Grande DA, SS Southerland, R Manji, DW Pate, SE Schwartz and PA Lucas. (1995). Repair of articular cartilage defects using mesenchymal stem cells. Tissue Eng 1:345-353.
2. Haynesworth SE, J Goshima, VM Goldberg and AI Caplan. (1992). Characterization of cells with osteogenic potential from human marrow. Bone 13:81-88.
3. Toma C, MF Pittenger, KS Cahill, BJ Byrne and PD Kessler. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93-98.
4. Young RG, DL Butler, W Weber, SL Gordon and DJ Fink. (1997). Mesenchymal stem cell-based repair of rabbit Achilles tendon. Trans Orthop Res Soc 22:249.
5. Ringden O, M Uzunel, I Rasmusson, M Remberger, B Sundberg, H Lonnies, HU Marschall, A Dlugosz, A Szakos, Z Hassan, B Omazic, J Aschan, L Barkholt and K Le Blanc. (2006). Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397.
6. Ringden O, M Uzunel, B Sundberg, L Lonnies, S Nava, J Gustafsson, L Henningsohn and K Le Blanc. (2007). Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 21:2271-2276.
7. Haynesworth SE, MA Baber and AI Caplan. (1996). Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 166:585-592.
8. Majumdar MK, MA Thiede, JD Mosca, M Moorman and SL Gerson. (1998). Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176:57-66.
9. Cheng L, P Qasba, P Vanguri and MA Thiede. (2000). Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells. J Cell Physiol 184:58-69.
10. Mbalaviele G, N Jaiswal, A Meng, L Cheng, C Van Den Bos and M Thiede. (1999). Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology 140:3736-3743.
11. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
12. Almeida-Porada G, AW Flake, HA Glimp and ED Zanjani. (1999). Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol 27:1569-1575.
13. Anker PS, WA Noort, AB Kruisselbrink, SA Scherjon, W Beekhuizen, R Willemze, HH Kanhai and WE Fibbe. (2003). Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 31:881-889.
14. Maitra B, E Szekely, K Gjini, MJ Laughlin, J Dennis, SE Haynesworth and ON Koc. (2004). Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33:597-604.
15. Koc ON, SL Gerson, BW Cooper, SM Dyhouse, SE Haynesworth, AI Caplan and HM Lazarus. (2000). Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and cultureexpanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18:307-316.
16. Ball LM, ME Bernardo, H Roelofs, A Lankester, A Cometa, RM Egeler, F Locatelli and WE Fibbe. (2007). Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110: 2764-2767.
17. Lazarus HM, ON Koc, SM Devine, P Curtin, RT Maziarz, HK Holland, EJ Shpall, P McCarthy, K Atkinson, BW Cooper, SL Gerson, MJ Laughlin, FR Loberiza, Jr., AB Moseley and A Bacigalupo. (2005). Cotransplantation of HLA-identical sibling culture expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11:389-398.
18. Le Blanc K, H Samuelsson, B Gustafsson, M Remberger, B Sundberg, J Arvidson, P Ljungman, H Lonnies, S Nava and O Ringden. (2007). Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21:1733-1738.
19. Macmillan ML, BR Blazar, TE DeFor and JE Wagner. (2009). Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant 43:447-454.
20. Le Blanc K and O Ringden. (2005). Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:321-334.
21. Mattsson J, O Ringden and R Storb. (2008). Graft failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 14:165-170.
22. Dreger P, M Suttorp, T Haferlach, H Loffler, N Schmitz and W Schroyens. (1993). Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 81:1404-1407.
23. Larocca A, G Piaggio, M Podesta, A Pitto, B Bruno, C Di Grazia, F Gualandi, D Occhini, AM Raiola, A Dominietto, S Bregante, T Lamparelli, E Tedone, R Oneto, F Frassoni, MT Van Lint, E Pogliani and A Bacigalupo. (2006). Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. Haematologica 91:935-940.
24. Meuleman N, T Tondreau, I Ahmad, J Kwan, F Crokaert, A Delforge, C Dorval, P Martiat, P Lewalle, L Lagneaux, and D Bron. (2009). Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study. Stem Cells Dev 10:xxxx-xxxx.
25. Karlsson H, S Samarasinghe, LM Ball, B Sundberg, AC Lankester, F Dazzi, M Uzunel, K Rao, P Veys, K Le Blanc, O Ringden and PJ Amrolia. (2008). Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. Blood 112:532-541.
26. Ringden O, M Labopin, NC Gorin, K Le Blanc, V Rocha, E Gluckman, J Reiffers, W Arcese, JM Vossen, JP Jouet, C Cordonnier and F Frassoni. (2004). Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 22:416-423.
27. Shimoda K, S Okamura, S Inaba, T Okamura, S Ohga, K Ueda and Y Niho. (1993). Granulocyte colony-stimulating factor and platelet aggregation. Lancet 341:633.
28. Svahn BM, O Alvin, O Ringden, A Gardulf and M Remberger. (2006). Costs of allogeneic hematopoietic stem cell transplantation. Transplantation 82:147-153.